NSPR
InspireMD, Inc.Company Information
- Company Name
- InspireMD, Inc.
- CIK
- CIK0001433607
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NSPR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- NSPR
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-27
- Last sale
- 2026-05-19
- Shares purchased (TTM)
- 365,354
- Shares sold (TTM)
- 24,778
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 21,080,800
- Shares outstanding
- 84,659,943
- Ownership
- 24.90%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -13.27%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 15 | 11 | 9 | 63 | 12 | 12 | 19 | 16 | 28 | 9 | 10 | 14 | ||||||
| Marketable Securities Current | 15 | 30 | 45 | - | 8 | 14 | 16 | 25 | 19 | 25 | 29 | 29 | ||||||
Accounts Receivable Net Current | ||||||||||||||||||
| Accounts Receivable Net Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | ||||||
| Nontrade Receivables Current | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 37 | 49 | 61 | 70 | 25 | 32 | 41 | 46 | 52 | 39 | 44 | 47 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Inventory Net | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 2 | 3 | 3 | 3 | 0 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 8 | 8 | 8 | 8 | 8 | 7 | 6 | 4 | 4 | 4 | 3 | 3 | ||||||
| Defined Benefit Plan Assets For Plan Benefits Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 45 | 56 | 69 | 78 | 33 | 39 | 47 | 50 | 56 | 42 | 48 | 50 | ||||||
Accounts Payable And Accrued Liabilities Current | ||||||||||||||||||
| Accounts Payable Trade Current | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable Other Current | 8 | 7 | 9 | 9 | 8 | 6 | 6 | 6 | 6 | 4 | 5 | 4 | ||||||
| Liabilities Current | 10 | 9 | 11 | 11 | 9 | 7 | 8 | 7 | 7 | 5 | 6 | 5 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 13 | 13 | 14 | 14 | 13 | 10 | 11 | 9 | 9 | 7 | 8 | 7 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 362 | 360 | 357 | 355 | 298 | 293 | 290 | 286 | 283 | 264 | 261 | 259 | ||||||
| Stockholders Equity | 32 | 44 | 55 | 64 | 20 | 28 | 36 | 41 | 47 | 35 | 40 | 43 | ||||||
| Retained Earnings Accumulated Deficit | -330 | -316 | -302 | -291 | -278 | -265 | -254 | -244 | -236 | -229 | -222 | -216 | ||||||
| Liabilities And Stockholders Equity | 45 | 56 | 69 | 78 | 33 | 39 | 47 | 50 | 56 | 42 | 48 | 50 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 47 | 47 | 44 | 42 | 33 | 30 | 27 | 26 | 25 | 23 | 22 | 21 | ||||||
| Shares Outstanding | 47 | 47 | 44 | 42 | 33 | 30 | 27 | 26 | 25 | 23 | 22 | 21 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInspireMD, Inc. (NSPR) — SEC Financial Statements & Analysis
InspireMD, Inc. (NSPR) is a surgical & medical instruments & apparatus company, incorporated in DE. InspireMD, Inc. trades on Nasdaq as: NSPR. InspireMD, Inc. (NSPR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, InspireMD, Inc. carries a market cap of $59.26M, a P/E ratio of -1.13x, a P/B ratio of 1.88x, a P/S ratio of 5.47x, an enterprise value of $44.11M, and an EV/EBITDA multiple of -0.83x. On profitability, it posts a gross margin of 18.05%, an operating margin of -494.03%, a net margin of -484.11%, a Return on Equity (ROE) of -202.81%, a Return on Assets (ROA) of -134.60%, and a Return on Invested Capital (ROIC) of -420.82%. Per share, it reports EPS of $-0.62, diluted EPS of $-0.62, free cash flow per share of $-0.50, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 53.42% year-over-year, net income growth of 26.83% year-over-year, and EPS growth of -23.59% year-over-year. On the balance sheet, it maintains a current ratio of 3.80x, a quick ratio of 3.40x, working capital of $26.98M, a debt-to-equity ratio of 0.42x, a debt ratio of 0.29, free cash flow of $-42.46M (TTM), and net debt of $-15.15M. Figures sourced from SEC EDGAR.
- Market Cap
- $59.26M
- P/E TTM
- -1.13x
- EPS TTM
- $-0.62
- P/B TTM
- 1.88x
- ROE TTM
- -202.81%
- ROA TTM
- -134.60%
- Debt To Equity
- 0.42x
- Free Cash Flow TTM
- $-42.46M
- Net Revenue TTM Growth 1Y
- 53.42%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is InspireMD, Inc. in?
InspireMD, Inc. (NSPR) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does NSPR trade on?
InspireMD, Inc. (NSPR) trades on the Nasdaq.
Where is InspireMD, Inc. incorporated?
InspireMD, Inc. is incorporated in DE.
When was InspireMD, Inc. (NSPR)'s most recent SEC filing?
InspireMD, Inc. (NSPR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is NSPR's market cap?
InspireMD, Inc. (NSPR) has a market capitalization of $59.26M as of 2026-06-30.
What is NSPR's EPS (earnings per share)?
InspireMD, Inc. (NSPR)'s trailing twelve month EPS is $-0.62 as of 2026-06-30.
What is NSPR's ROE (return on equity)?
InspireMD, Inc. (NSPR)'s trailing twelve month Return on Equity (ROE) is -202.81% as of 2026-06-30.
What is NSPR's ROA (return on assets)?
InspireMD, Inc. (NSPR)'s trailing twelve month Return on Assets (ROA) is -134.60% as of 2026-06-30.
What is NSPR's ROIC (return on invested capital)?
InspireMD, Inc. (NSPR)'s trailing twelve month Return on Invested Capital (ROIC) is -420.82% as of 2026-06-30.
What is NSPR's EV/EBITDA?
InspireMD, Inc. (NSPR)'s trailing twelve month EV/EBITDA is -0.83x as of 2026-06-30.